<DOC>
	<DOC>NCT01137916</DOC>
	<brief_summary>The objective of the present study is to evaluate the activity and safety of imatinib in patients with aggressive fibromatosis who, after receiving the standard therapy, show an inoperable recurrent tumor or disease not readily controllable by surgery or radiotherapy.</brief_summary>
	<brief_title>Study to Evaluate Imatinib in Desmoid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Aggression</mesh_term>
	<mesh_term>Fibromatosis, Aggressive</mesh_term>
	<mesh_term>Fibroma</mesh_term>
	<mesh_term>Imatinib Mesylate</mesh_term>
	<criteria>Patients with histological confirmed aggressive fibromatosis (desmoid tumor) Measurable disease according to the RECIST criteria Evidence of relapse or disease progression within the last 6 months (based on RECIST criteria) in computed tomography or magnetic resonance imaging No possibility of complete surgical resection or cases in which surgical therapy leaving a large tissue defect, functional deficit or disfigurement would be required No possibility of curative radiotherapy with acceptable toxicity and/or late morbidity Previous treatment of the tumor region by surgical intervention and/or radiotherapy and/or antihormonal therapy possible Age &gt; or = 18 years WHO PS &lt; or = 1 Effective contraception during study medication Signed informed consent form Surgical intervention &lt; 4 weeks Prior therapy with imatinib Pregnancy or lactation Severe hepatic dysfunction Known allergic reaction to imatinib or one of its components The following laboratory values: Absolute neutrophil count &lt; 1.5 x 103/mm3, Platelets &lt; 100,000/mm3, Serum creatinine &gt; or = 2.5 mg/dl, SGOT and/or SGPT &gt; 2.5 x ULN (upper limit of normal), Total bilirubin &gt; 1.5 x ULN Participation in another study (four weeks before and during the study) Prior malignancy apart from completely resected basal cell carcinoma of the skin or carcinoma in situ of the uterine cervix</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>